NEWS
< back to news list

NanOX Recovery Box undergoes operational testing of new prototype – a key step in the development of a device that could revolutionize transplantology

NanoGroup S.A. is currently conducting operational tests of the latest prototype of the NanOX Recovery Box – an innovative device for storing and perfusing organs intended for transplantation. This is another, extremely important stage in the development of this breakthrough technology, aimed at improving the quality and extending the storage time of organs. The tests are taking place at the Institute of Animal Physiology and Nutrition of the Polish Academy of Sciences in Jabłonna, under the supervision of experienced specialists.

NanOX Recovery Box is a breakthrough in transplant medicine – the device, developed by Polish scientists from NanoGroup, enables advanced control of vital organ functions in conditions that are similar to natural physiological processes. The latest version of the prototype, which uses standardized components and the latest technological procedures, was created in cooperation with the Wrocław company A4BEE, specializing in the design of modern medical devices.

– NanOX Recovery Box is not only a device for storing organs – it is an advanced system that monitors their vital functions in a much more advanced way than any other available solution
– explains Prof. Maciej Kosieradzki, Ph. n. med., from the Medical University of Warsaw, emphasizing the uniqueness of this phase of research.
– Thanks to this, we can provide better storage conditions, which can significantly increase the pool of organs for transplantation, including from donors who have not previously qualified for organ donation– adds the expert.

Wet tests – another milestone in technology development

The operational tests, known as “wet,” are performed on isolated pig kidneys in controlled conditions that simulate the actual transplant environment. For 12 hours, the device monitors and regulates key parameters such as temperature, pressure, pH, and oxygenation, as well as ensuring adequate perfusion fluid flow through the organ.

– Successfully reproducing our device in A4BEE laboratories is an important development step on the path to device certification. The next development step will be to develop a production version of the device, prepare full certification documentation and submit an application for certification. Commercialization of this solution, combined with our innovative NanOX 4Kidney perfusion fluid, may change the future of transplantology worldwide. – dodaje Przemysław Mazurek, prezes zarządu NanoGroup S.A.

NanOX Recovery Box is the future of transplant medicine, the device can not only extend the storage time of organs, but also opens up new possibilities in increasing the number of organs available for transplantation.

IMG_6430
IMG_6504
IMG_6529
IMG_6535
PHOTO-2024-09-26-22-27-33 2
PHOTO-2024-09-26-22-27-33 3
PHOTO-2024-09-26-22-27-33 4
PHOTO-2024-09-26-22-27-33
PHOTO-2024-09-26-22-48-45
Copyright © NanoGroup 2024

Prof. Tomasz Ciach

Founder, Member of the Management Board of NANOGROUP S.A.

Nanotechnology expert. Professor at the Faculty of Chemical and Processing Engineering, Warsaw University of Technology, head of the Biotechnology and Bioprocessing Division. Author of two technologies that are already in production stage, 12 granted patents and over 50 publications. Founder of BioMedLab research group, consultant in numerous companies (AstraZeneca, Procter and Gamble, Reckit, Adamed, Balton, Galmed). Work on various aspects of Biomedical Engineering, mostly on biomedical nanotechnology, active coatings for medical implants, nanoparticles for cancer treatment, biodegradable and nonbiodegradable implants, bone and vascular prosthesis. He gives rare, but already brilliant example of how brave ideas become socially and financially valuable.

Piotr Mierzejewski

Vice President of the Management Board of NANOGROUP S.A.

Clinical pharmacology specialist, former advisor to the Minister of Health on drug policy. He negotiated Poland’s accession to the EU in the field of pharmacy, responsible for the implementation of EU directives in the field of pharmacy into the Polish legal system. Co-founder of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products. Owner of a consulting company cooperating with international pharmaceutical companies in the field of introducing new technologies to the Polish market.

Przemysław Mazurek

President of the Management Board of NANOGROUP S.A.

Associated with the health market since 2004. As Managing Director, he restructured and developed the most dynamically operating Medical Center in the Podkarpacie region, creating and setting new standards of customer service quality on the market. Co-creator of the first solution in Poland for online registration of medical appointments. Co-founder of the first and only Infertility Treatment Clinic (MEDICOR) in Podkarpacie, which he headed as the President until 2009. He was responsible for the development of health insurance in the PZU Group. As Vice President of PZU Pomoc S.A. created the largest medical TPA in Poland to handle health insurance. Co-founder of the first drug insurance in Poland. Since 2015, he has been active in the field of Wealth Management and advises on management and finance. A graduate of International Economic and Political Relations as well as Management and Marketing at the Warsaw School of Economics.

Przemysław Mazurek

President of the Management Board of NANOGROUP S.A.

Associated with the health market since 2004. As Managing Director, he restructured and developed the most dynamically operating Medical Center in the Podkarpacie region, creating and setting new standards of customer service quality on the market. Co-creator of the first solution in Poland for online registration of medical appointments. Co-founder of the first and only Infertility Treatment Clinic (MEDICOR) in Podkarpacie, which he headed as the President until 2009. He was responsible for the development of health insurance in the PZU Group. As Vice President of PZU Pomoc S.A. created the largest medical TPA in Poland to handle health insurance. Co-founder of the first drug insurance in Poland. Since 2015, he has been active in the field of Wealth Management and advises on management and finance. A graduate of International Economic and Political Relations as well as Management and Marketing at the Warsaw School of Economics.